Global Active Pharmaceutical Ingredients Industry to 2026 – Pfizer, AbbVie and Novartis among others

0

DUBLIN, January 20, 2022–(BUSINESS WIRE)–The “Global Active Pharmaceutical Ingredients (APIs) Market – Analysis by Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), by Application, by Region, by Country (2021 Edition): Market Overview and Forecast with Market Impact COVID-19 (2021-2026)” report has been added to from ResearchAndMarkets.com offer.

According to this report, the global active pharmaceutical ingredients market is expected to show robust growth represented by a CAGR of 6.96% during the period 2021-2026.

Profiled companies

The global active pharmaceutical ingredients market was valued at USD 179.6 billion in 2020. The growth opportunities for the active pharmaceutical ingredients market are attributed to growing geriatric population, increase in technical advancements, growing increase in API manufacturing facilities around the world and the growing number of researches. and development activities by some of the major players in the global platform market.

Rising awareness as well as investment in new drug development in the market is increasing the number of clinical trials globally, which is driving up the active pharmaceutical ingredient market. With the increasing prevalence of respiratory diseases due to the COVID-19 outbreak, it is expected that there will be more demand for new drugs, which is likely to push the demand for APIs and consequently increase ‘affect the global active pharmaceutical market in the world.

Biopharmaceutical companies opt for mergers and acquisitions to access new technologies, expand their market and increase their capital for clinical trials and investments. The API market has experienced impressive growth in recent years. This growth trend is expected to continue due to increased demand from the Asia-Pacific region in the future. This is mainly due to China, India, and Japan, which consist of a huge population and therefore a huge incidence of infectious diseases that require drugs for treatment.

The rising death toll and the spread of the virus have prompted many pharmaceutical companies, biopharmaceutical companies and small startups to collaborate and come up with effective drugs to fight the same. Scientists around the world have found molecules that can effectively target COVID-19. Currently, 155 molecules are under clinical investigation and 45 molecules are in preclinical development to be targeted against COVID-19. Locally monitored businesses to protect the safety of study participants, staff and employees during these times.

Report scope

  • The report presents the Active Pharmaceutical Ingredients market analysis for the historical period 2016-2020 and the forecast period 2021-2026.

  • The report analyzes the active pharmaceutical ingredients market by value (USD billion)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Application (Oncology, Cardiology, Diabetes, Neurology and Others)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Drug Type (Generic API and Innovative API)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Synthesis (synthetic and biotech)

  • The Global Active Pharmaceutical Ingredients Market has been analyzed by Region (North America, Europe, Asia-Pacific and LAMEA)

  • The Global Active Pharmaceutical Ingredients Market has been analyzed by country (USA, Canada, Germany, France, UK, Italy, Spain, China, Japan and India)

  • The attractiveness of the market has been presented by region, by application, by drug type and by synthesis.

  • Also, major industry opportunities, trends, drivers, and challenges have been analyzed in the report.

Main topics covered:

1. Report Scope and Methodology

2. Strategic Recommendations

3. Active Pharmaceutical Ingredients Market: Product Outlook

4. Global Active Pharmaceutical Ingredients Market: Size and Forecast

4.1 Global Active Pharmaceutical Ingredients Market Size, by Value, Year 2016- 2026

5. Global Active Pharmaceutical Ingredients Market Segmentation- By Application, By Drug Type, By Synthesis

6. Global Active Pharmaceutical Ingredients Market: Regional Analysis

7. North America Active Pharmaceutical Ingredients Market: An Analysis (2016-2026)

8. Europe Active Pharmaceutical Ingredients Market: Segmentation: An Analysis (2016-2026)

9. Asia-Pacific Active Pharmaceutical Ingredients Market: An Analysis (2016-2026)

10. Global Active Pharmaceutical Ingredients Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends

11. Market attractiveness

11.1 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Application, 2026

11.2 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Drug Type, 2026

11.3 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Synthesis, 2026

11.4 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Region, 2026

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

12.2 Market Share Analysis

13. Business Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/xf3hs1

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220120005561/en/

contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Officer
[email protected]
For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900

Share.

Comments are closed.